- Forums
- ASX - By Stock
- BOT
- Ann: BTX 1702 Rosacea Study Approval
Ann: BTX 1702 Rosacea Study Approval, page-4
-
- There are more pages in this discussion • 98 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
(20min delay)
|
|||||
Last
32.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $577.0M |
Open | High | Low | Value | Volume |
32.5¢ | 32.5¢ | 31.5¢ | $843.0K | 2.630M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
30 | 819697 | 31.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
32.5¢ | 396726 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
30 | 834673 | 0.315 |
30 | 969986 | 0.310 |
13 | 351601 | 0.305 |
33 | 610494 | 0.300 |
8 | 231012 | 0.295 |
Price($) | Vol. | No. |
---|---|---|
0.325 | 413294 | 13 |
0.330 | 176860 | 7 |
0.335 | 344000 | 4 |
0.340 | 652896 | 6 |
0.345 | 919199 | 10 |
Last trade - 12.24pm 15/11/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online